Cargando…

Preventing substance misuse: study protocol for a randomised controlled trial of the Strengthening Families Programme 10–14 UK (SFP 10–14 UK)

BACKGROUND: Prevention of alcohol, drug and tobacco misuse by young people is a key public health priority. There is a need to develop the evidence base through rigorous evaluations of innovative approaches to substance misuse prevention. The Strengthening Families Programme 10–14 is a universal fam...

Descripción completa

Detalles Bibliográficos
Autores principales: Segrott, Jeremy, Gillespie, David, Holliday, Jo, Humphreys, Ioan, Murphy, Simon, Phillips, Ceri, Reed, Hayley, Rothwell, Heather, Foxcroft, David, Hood, Kerenza, Roberts, Zoe, Scourfield, Jonathan, Thomas, Claire, Moore, Laurence
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3902023/
https://www.ncbi.nlm.nih.gov/pubmed/24438460
http://dx.doi.org/10.1186/1471-2458-14-49
_version_ 1782300940804554752
author Segrott, Jeremy
Gillespie, David
Holliday, Jo
Humphreys, Ioan
Murphy, Simon
Phillips, Ceri
Reed, Hayley
Rothwell, Heather
Foxcroft, David
Hood, Kerenza
Roberts, Zoe
Scourfield, Jonathan
Thomas, Claire
Moore, Laurence
author_facet Segrott, Jeremy
Gillespie, David
Holliday, Jo
Humphreys, Ioan
Murphy, Simon
Phillips, Ceri
Reed, Hayley
Rothwell, Heather
Foxcroft, David
Hood, Kerenza
Roberts, Zoe
Scourfield, Jonathan
Thomas, Claire
Moore, Laurence
author_sort Segrott, Jeremy
collection PubMed
description BACKGROUND: Prevention of alcohol, drug and tobacco misuse by young people is a key public health priority. There is a need to develop the evidence base through rigorous evaluations of innovative approaches to substance misuse prevention. The Strengthening Families Programme 10–14 is a universal family-based alcohol, drugs and tobacco prevention programme, which has achieved promising results in US trials, and which now requires cross-cultural assessment. This paper therefore describes the protocol for a randomised controlled trial of the UK version of the Strengthening Families Programme 10–14 (SFP 10–14 UK). METHODS/DESIGN: The trial comprises a pragmatic cluster randomised controlled effectiveness trial with families as the unit of randomisation, with embedded process and economic evaluations. Participating families will be randomised to one of two treatment groups - usual care with full access to existing services (control group), or usual care plus SFP 10–14 UK (intervention group). The trial has two primary outcomes - the number of occasions that young people report having drunk alcohol in the last 30 days, and drunkenness during the last 30 days, both dichotomised as ‘never’ and ‘1-2 times or more’. The main follow-up is at 2 years past baseline, and short-term and intermediate outcomes are also measured at 9 and 15 months. DISCUSSION: The results from this trial will provide evidence on the effectiveness and cost-effectiveness of an innovative universal family-based substance misuse prevention programme in a UK context. TRIAL REGISTRATION: Current Controlled Trials ISRCTN63550893.
format Online
Article
Text
id pubmed-3902023
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-39020232014-01-26 Preventing substance misuse: study protocol for a randomised controlled trial of the Strengthening Families Programme 10–14 UK (SFP 10–14 UK) Segrott, Jeremy Gillespie, David Holliday, Jo Humphreys, Ioan Murphy, Simon Phillips, Ceri Reed, Hayley Rothwell, Heather Foxcroft, David Hood, Kerenza Roberts, Zoe Scourfield, Jonathan Thomas, Claire Moore, Laurence BMC Public Health Study Protocol BACKGROUND: Prevention of alcohol, drug and tobacco misuse by young people is a key public health priority. There is a need to develop the evidence base through rigorous evaluations of innovative approaches to substance misuse prevention. The Strengthening Families Programme 10–14 is a universal family-based alcohol, drugs and tobacco prevention programme, which has achieved promising results in US trials, and which now requires cross-cultural assessment. This paper therefore describes the protocol for a randomised controlled trial of the UK version of the Strengthening Families Programme 10–14 (SFP 10–14 UK). METHODS/DESIGN: The trial comprises a pragmatic cluster randomised controlled effectiveness trial with families as the unit of randomisation, with embedded process and economic evaluations. Participating families will be randomised to one of two treatment groups - usual care with full access to existing services (control group), or usual care plus SFP 10–14 UK (intervention group). The trial has two primary outcomes - the number of occasions that young people report having drunk alcohol in the last 30 days, and drunkenness during the last 30 days, both dichotomised as ‘never’ and ‘1-2 times or more’. The main follow-up is at 2 years past baseline, and short-term and intermediate outcomes are also measured at 9 and 15 months. DISCUSSION: The results from this trial will provide evidence on the effectiveness and cost-effectiveness of an innovative universal family-based substance misuse prevention programme in a UK context. TRIAL REGISTRATION: Current Controlled Trials ISRCTN63550893. BioMed Central 2014-01-17 /pmc/articles/PMC3902023/ /pubmed/24438460 http://dx.doi.org/10.1186/1471-2458-14-49 Text en Copyright © 2014 Segrott et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Study Protocol
Segrott, Jeremy
Gillespie, David
Holliday, Jo
Humphreys, Ioan
Murphy, Simon
Phillips, Ceri
Reed, Hayley
Rothwell, Heather
Foxcroft, David
Hood, Kerenza
Roberts, Zoe
Scourfield, Jonathan
Thomas, Claire
Moore, Laurence
Preventing substance misuse: study protocol for a randomised controlled trial of the Strengthening Families Programme 10–14 UK (SFP 10–14 UK)
title Preventing substance misuse: study protocol for a randomised controlled trial of the Strengthening Families Programme 10–14 UK (SFP 10–14 UK)
title_full Preventing substance misuse: study protocol for a randomised controlled trial of the Strengthening Families Programme 10–14 UK (SFP 10–14 UK)
title_fullStr Preventing substance misuse: study protocol for a randomised controlled trial of the Strengthening Families Programme 10–14 UK (SFP 10–14 UK)
title_full_unstemmed Preventing substance misuse: study protocol for a randomised controlled trial of the Strengthening Families Programme 10–14 UK (SFP 10–14 UK)
title_short Preventing substance misuse: study protocol for a randomised controlled trial of the Strengthening Families Programme 10–14 UK (SFP 10–14 UK)
title_sort preventing substance misuse: study protocol for a randomised controlled trial of the strengthening families programme 10–14 uk (sfp 10–14 uk)
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3902023/
https://www.ncbi.nlm.nih.gov/pubmed/24438460
http://dx.doi.org/10.1186/1471-2458-14-49
work_keys_str_mv AT segrottjeremy preventingsubstancemisusestudyprotocolforarandomisedcontrolledtrialofthestrengtheningfamiliesprogramme1014uksfp1014uk
AT gillespiedavid preventingsubstancemisusestudyprotocolforarandomisedcontrolledtrialofthestrengtheningfamiliesprogramme1014uksfp1014uk
AT hollidayjo preventingsubstancemisusestudyprotocolforarandomisedcontrolledtrialofthestrengtheningfamiliesprogramme1014uksfp1014uk
AT humphreysioan preventingsubstancemisusestudyprotocolforarandomisedcontrolledtrialofthestrengtheningfamiliesprogramme1014uksfp1014uk
AT murphysimon preventingsubstancemisusestudyprotocolforarandomisedcontrolledtrialofthestrengtheningfamiliesprogramme1014uksfp1014uk
AT phillipsceri preventingsubstancemisusestudyprotocolforarandomisedcontrolledtrialofthestrengtheningfamiliesprogramme1014uksfp1014uk
AT reedhayley preventingsubstancemisusestudyprotocolforarandomisedcontrolledtrialofthestrengtheningfamiliesprogramme1014uksfp1014uk
AT rothwellheather preventingsubstancemisusestudyprotocolforarandomisedcontrolledtrialofthestrengtheningfamiliesprogramme1014uksfp1014uk
AT foxcroftdavid preventingsubstancemisusestudyprotocolforarandomisedcontrolledtrialofthestrengtheningfamiliesprogramme1014uksfp1014uk
AT hoodkerenza preventingsubstancemisusestudyprotocolforarandomisedcontrolledtrialofthestrengtheningfamiliesprogramme1014uksfp1014uk
AT robertszoe preventingsubstancemisusestudyprotocolforarandomisedcontrolledtrialofthestrengtheningfamiliesprogramme1014uksfp1014uk
AT scourfieldjonathan preventingsubstancemisusestudyprotocolforarandomisedcontrolledtrialofthestrengtheningfamiliesprogramme1014uksfp1014uk
AT thomasclaire preventingsubstancemisusestudyprotocolforarandomisedcontrolledtrialofthestrengtheningfamiliesprogramme1014uksfp1014uk
AT moorelaurence preventingsubstancemisusestudyprotocolforarandomisedcontrolledtrialofthestrengtheningfamiliesprogramme1014uksfp1014uk